Military Medical Research最新文献

筛选
英文 中文
AKR1C3 as a therapeutic target to overcome erlotinib resistance in lung adenocarcinoma.
IF 16.7 2区 医学
Military Medical Research Pub Date : 2025-02-17 DOI: 10.1186/s40779-025-00593-4
William C Cho, Kwan P Li, Chi F Wong, King Y Fung, James C H Chow, Ka M Cheung, Jeffrey C H Chan, Eunice Y T Lau
{"title":"AKR1C3 as a therapeutic target to overcome erlotinib resistance in lung adenocarcinoma.","authors":"William C Cho, Kwan P Li, Chi F Wong, King Y Fung, James C H Chow, Ka M Cheung, Jeffrey C H Chan, Eunice Y T Lau","doi":"10.1186/s40779-025-00593-4","DOIUrl":"10.1186/s40779-025-00593-4","url":null,"abstract":"","PeriodicalId":18581,"journal":{"name":"Military Medical Research","volume":"12 1","pages":"8"},"PeriodicalIF":16.7,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11834314/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143441327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence.
IF 16.7 2区 医学
Military Medical Research Pub Date : 2025-02-11 DOI: 10.1186/s40779-025-00595-2
Muhammad Tufail, Can-Hua Jiang, Ning Li
{"title":"Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence.","authors":"Muhammad Tufail, Can-Hua Jiang, Ning Li","doi":"10.1186/s40779-025-00595-2","DOIUrl":"10.1186/s40779-025-00595-2","url":null,"abstract":"<p><p>Cancer recurrence, driven by the phenomenon of tumor dormancy, presents a formidable challenge in oncology. Dormant cancer cells have the ability to evade detection and treatment, leading to relapse. This review emphasizes the urgent need to comprehend tumor dormancy and its implications for cancer recurrence. Despite notable advancements, significant gaps remain in our understanding of the mechanisms underlying dormancy and the lack of reliable biomarkers for predicting relapse. This review provides a comprehensive analysis of the cellular, angiogenic, and immunological aspects of dormancy. It highlights the current therapeutic strategies targeting dormant cells, particularly combination therapies and immunotherapies, which hold promise in preventing relapse. By elucidating these mechanisms and proposing innovative research methodologies, this review aims to deepen our understanding of tumor dormancy, ultimately facilitating the development of more effective strategies for preventing cancer recurrence and improving patient outcomes.</p>","PeriodicalId":18581,"journal":{"name":"Military Medical Research","volume":"12 1","pages":"7"},"PeriodicalIF":16.7,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11812268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143399474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy.
IF 16.7 2区 医学
Military Medical Research Pub Date : 2025-01-28 DOI: 10.1186/s40779-025-00590-7
Xin-Yu Zhu, Wei-Yi Zhou, Tuo Li
{"title":"Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy.","authors":"Xin-Yu Zhu, Wei-Yi Zhou, Tuo Li","doi":"10.1186/s40779-025-00590-7","DOIUrl":"10.1186/s40779-025-00590-7","url":null,"abstract":"","PeriodicalId":18581,"journal":{"name":"Military Medical Research","volume":"12 1","pages":"3"},"PeriodicalIF":16.7,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11776112/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143059771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective analysis of US veterans with inclusion body myositis: initial findings from the Veterans Affairs Corporate Data Warehouse.
IF 16.7 2区 医学
Military Medical Research Pub Date : 2025-01-28 DOI: 10.1186/s40779-025-00592-5
Vladimir M Liarski
{"title":"Retrospective analysis of US veterans with inclusion body myositis: initial findings from the Veterans Affairs Corporate Data Warehouse.","authors":"Vladimir M Liarski","doi":"10.1186/s40779-025-00592-5","DOIUrl":"10.1186/s40779-025-00592-5","url":null,"abstract":"","PeriodicalId":18581,"journal":{"name":"Military Medical Research","volume":"12 1","pages":"6"},"PeriodicalIF":16.7,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11773961/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143059773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Build the virtual cell with artificial intelligence: a perspective for cancer research.
IF 16.7 2区 医学
Military Medical Research Pub Date : 2025-01-27 DOI: 10.1186/s40779-025-00591-6
Tao Yang, Yuan-Yi Wang, Fei Ma, Bing-He Xu, Hai-Li Qian
{"title":"Build the virtual cell with artificial intelligence: a perspective for cancer research.","authors":"Tao Yang, Yuan-Yi Wang, Fei Ma, Bing-He Xu, Hai-Li Qian","doi":"10.1186/s40779-025-00591-6","DOIUrl":"10.1186/s40779-025-00591-6","url":null,"abstract":"","PeriodicalId":18581,"journal":{"name":"Military Medical Research","volume":"12 1","pages":"4"},"PeriodicalIF":16.7,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11770950/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143052753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies. MELK 通过稳定肝细胞恶性肿瘤中的 FABP5 防止射频消融诱导的免疫原性细胞死亡和抗肿瘤免疫反应。
IF 16.7 2区 医学
Military Medical Research Pub Date : 2025-01-27 DOI: 10.1186/s40779-024-00588-7
Bu-Fu Tang, Wang-Ting Xu, Shi-Ji Fang, Jin-Yu Zhu, Rong-Fang Qiu, Lin Shen, Yang Yang, Qiao-You Weng, Ya-Jie Wang, Jia-Yi Ding, Xiao-Jie Zhang, Wei-Qian Chen, Li-Yun Zheng, Jing-Jing Song, Biao Chen, Zhong-Wei Zhao, Min-Jiang Chen, Jian-Song Ji
{"title":"MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies.","authors":"Bu-Fu Tang, Wang-Ting Xu, Shi-Ji Fang, Jin-Yu Zhu, Rong-Fang Qiu, Lin Shen, Yang Yang, Qiao-You Weng, Ya-Jie Wang, Jia-Yi Ding, Xiao-Jie Zhang, Wei-Qian Chen, Li-Yun Zheng, Jing-Jing Song, Biao Chen, Zhong-Wei Zhao, Min-Jiang Chen, Jian-Song Ji","doi":"10.1186/s40779-024-00588-7","DOIUrl":"10.1186/s40779-024-00588-7","url":null,"abstract":"<p><strong>Background: </strong>Radiofrequency ablation (RFA) is an efficient treatment with unlimited potential for liver cancer that can effectively reduce patient mortality. Understanding the biological process related with RFA treatment is important for improving treatment strategy. This study aimed to identify the critical targets for regulating the efficacy of RFA.</p><p><strong>Methods: </strong>The RFA treatment in hepatocellular carcinoma (HCC) tumor models in vivo, was analyzed by RNA sequencing technology. The heat treatment in vitro for HCC tumor cells was also constructed to explore the mechanism after RFA treatment in tumor cells. Nanoparticles with high affinity to tumor cells were applied as a new therapy to interfere with the expression of maternal embryonic leucine zipper kinase (MELK).</p><p><strong>Results: </strong>It was found that RFA treatment upregulated MELK expression, and MELK inhibition promoted RFA efficacy by immunogenic cell death and the antitumor response, including anti-tumoral macrophage polarization and increased CD8<sup>+</sup> T cell cytotoxicity in HCC. Mechanically, MELK binds to fatty acid-binding protein 5 (FABP5), and affects its ubiquitination through the K48R pathway to increase its stability, thereby activating protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling axis to weaken the RFA-mediated antitumor effect. In addition, the synthesis of arginylglycylaspartic acid (RGD)-lipid nanoparticles (LNPs) targeting tumor cell-intrinsic MELK enhanced RFA efficacy in HCC.</p><p><strong>Conclusion: </strong>MELK is a therapeutic target by regulating RFA efficacy in HCC, and targeting MELK via RGD-LNPs provides new insight into improving RFA efficacy in HCC clinical treatment and combating the malignant progression of liver cancer.</p>","PeriodicalId":18581,"journal":{"name":"Military Medical Research","volume":"12 1","pages":"5"},"PeriodicalIF":16.7,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11773770/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143052756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short-term suborbital space flight curtails astronauts' dopamine levels increasing cortisol/BDNF and prompting pro-oxidative/inflammatory milieu. 短期的亚轨道太空飞行减少了宇航员的多巴胺水平,增加了皮质醇/BDNF,促进了促氧化/炎症环境。
IF 16.7 2区 医学
Military Medical Research Pub Date : 2025-01-20 DOI: 10.1186/s40779-025-00589-0
Gerardo Bosco, Angelo Landolfi, Tommaso Antonio Giacon, Alessandra Vezzoli, Nazareno Paolocci, Simona Mrakic-Sposta
{"title":"Short-term suborbital space flight curtails astronauts' dopamine levels increasing cortisol/BDNF and prompting pro-oxidative/inflammatory milieu.","authors":"Gerardo Bosco, Angelo Landolfi, Tommaso Antonio Giacon, Alessandra Vezzoli, Nazareno Paolocci, Simona Mrakic-Sposta","doi":"10.1186/s40779-025-00589-0","DOIUrl":"https://doi.org/10.1186/s40779-025-00589-0","url":null,"abstract":"","PeriodicalId":18581,"journal":{"name":"Military Medical Research","volume":"12 1","pages":"2"},"PeriodicalIF":16.7,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744899/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143008400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing space medicine: a global perspective on in-orbit research and future directions. 推进空间医学:在轨研究的全球视角和未来方向。
IF 16.7 2区 医学
Military Medical Research Pub Date : 2025-01-03 DOI: 10.1186/s40779-024-00587-8
Shan-Guang Chen, Xiao-Ping Chen, Bin Wu
{"title":"Advancing space medicine: a global perspective on in-orbit research and future directions.","authors":"Shan-Guang Chen, Xiao-Ping Chen, Bin Wu","doi":"10.1186/s40779-024-00587-8","DOIUrl":"10.1186/s40779-024-00587-8","url":null,"abstract":"","PeriodicalId":18581,"journal":{"name":"Military Medical Research","volume":"12 1","pages":"1"},"PeriodicalIF":16.7,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11697929/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142927365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dietary methionine supplementation promotes mice hematopoiesis after irradiation. 膳食补充蛋氨酸促进照射后小鼠造血功能。
IF 16.7 2区 医学
Military Medical Research Pub Date : 2024-12-20 DOI: 10.1186/s40779-024-00584-x
Wei-Wei Zhang, Yang Xiang, Li Chen, Shao-Ting Liu, Chuan-Chuan Lin, Jiu-Xuan Li, Li-Xin Xiang, Nan-Xi Chen, Dong-Ling Shi, Yang-Yang Zhang, Xue-Ying Wang, Lan-Yue Hu, Sai Chen, Ya Luo, Cheng-Ning Tan, Pei-Pei Xue, Yang-Zhou Jiang, Sheng-Wen Calvin Li, Zhen-Xing Yang, Ji-Gang Dai, Zhong-Jun Li, Qian Ran
{"title":"Dietary methionine supplementation promotes mice hematopoiesis after irradiation.","authors":"Wei-Wei Zhang, Yang Xiang, Li Chen, Shao-Ting Liu, Chuan-Chuan Lin, Jiu-Xuan Li, Li-Xin Xiang, Nan-Xi Chen, Dong-Ling Shi, Yang-Yang Zhang, Xue-Ying Wang, Lan-Yue Hu, Sai Chen, Ya Luo, Cheng-Ning Tan, Pei-Pei Xue, Yang-Zhou Jiang, Sheng-Wen Calvin Li, Zhen-Xing Yang, Ji-Gang Dai, Zhong-Jun Li, Qian Ran","doi":"10.1186/s40779-024-00584-x","DOIUrl":"10.1186/s40779-024-00584-x","url":null,"abstract":"<p><strong>Background: </strong>With the increasing risk of nuclear exposure, more attention has been paid to the prevention and treatment of acute radiation syndrome (ARS). Although amino acids are key nutrients involved in hematopoietic regulation, the impacts of amino acids on bone marrow hematopoiesis following irradiation and the associated mechanisms have not been fully elucidated. Hence, it is of paramount importance to study the changes in amino acid metabolism after irradiation and their effects on hematopoiesis as well as the related mechanisms.</p><p><strong>Methods: </strong>The content of serum amino acids was analyzed using metabolomic sequencing. The survival rate and body weight of the irradiated mice were detected after altering the methionine content in the diet. Extracellular matrix (ECM) protein analysis was performed via proteomics analysis. Inflammatory factors were examined by enzyme-linked immunosorbent assay (ELISA). Flow cytometry, Western blotting, and immunofluorescence were employed to determine the mechanism by which S100 calcium-binding protein A4 (S100A4) regulates macrophage polarization.</p><p><strong>Results: </strong>The survival time of irradiated mice was significantly associated with alterations in multiple amino acids, particularly methionine. A high methionine diet promoted irradiation tolerance, especially in the recovery of bone marrow hematopoiesis, yet with dose limitations. Folate metabolism could partially alleviate the dose bottleneck by reducing the accumulation of homocysteine. Mechanistically, high methionine levels maintained the abundance of ECM components, including collagens and glycoproteins, in the bone marrow post-irradiation, among which the level of S100A4 was significantly changed. S100A4 regulated macrophage polarization via the STAT3 pathway, inhibited bone marrow inflammation and facilitated the proliferation and differentiation of hematopoietic stem/progenitor cells.</p><p><strong>Conclusions: </strong>We have demonstrated that an appropriate elevation in dietary methionine enhances irradiation tolerance in mice and explains the mechanism by which methionine regulates bone marrow hematopoiesis after irradiation.</p>","PeriodicalId":18581,"journal":{"name":"Military Medical Research","volume":"11 1","pages":"83"},"PeriodicalIF":16.7,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11660814/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142864885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy. PD-1/PD-L1 信号轴在肿瘤发生中的作用以及生物活性天然化合物在癌症免疫疗法中的靶向作用。
IF 16.7 2区 医学
Military Medical Research Pub Date : 2024-12-18 DOI: 10.1186/s40779-024-00586-9
Yogesh Godiyal, Drishti Maheshwari, Hiroaki Taniguchi, Shweta S Zinzuwadia, Yanelys Morera-Díaz, Devesh Tewari, Anupam Bishayee
{"title":"Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy.","authors":"Yogesh Godiyal, Drishti Maheshwari, Hiroaki Taniguchi, Shweta S Zinzuwadia, Yanelys Morera-Díaz, Devesh Tewari, Anupam Bishayee","doi":"10.1186/s40779-024-00586-9","DOIUrl":"10.1186/s40779-024-00586-9","url":null,"abstract":"<p><p>Cancer is a global health problem and one of the leading causes of mortality. Immune checkpoint inhibitors have revolutionized the field of oncology, emerging as a powerful treatment strategy. A key pathway that has garnered considerable attention is programmed cell death-1 (PD-1)/programmed cell death ligand-1 (PD-L1). The interaction between PD-L1 expressed on tumor cells and PD-1 reduces the innate immune response and thus compromises the capability of the body's immune system. Furthermore, it controls the phenotype and functionality of innate and adaptive immune components. A range of monoclonal antibodies, including avelumab, atezolizumab, camrelizumab, dostarlimab, durvalumab, sinitilimab, toripalimab, and zimberelimab, have been developed for targeting the interaction between PD-1 and PD-L1. These agents can induce a broad spectrum of autoimmune-like complications that may affect any organ system. Recent studies have focused on the effect of various natural compounds that inhibit immune checkpoints. This could contribute to the existing arsenal of anticancer drugs. Several bioactive natural agents have been shown to affect the PD-1/PD-L1 signaling axis, promoting tumor cell apoptosis, influencing cell proliferation, and eventually leading to tumor cell death and inhibiting cancer progression. However, there is a substantial knowledge gap regarding the role of different natural compounds targeting PD-1 in the context of cancer. Hence, this review aims to provide a common connection between PD-1/PD-L1 blockade and the anticancer effects of distinct natural molecules. Moreover, the primary focus will be on the underlying mechanism of action as well as the clinical efficacy of bioactive molecules. Current challenges along with the scope of future research directions targeting PD-1/PD-L1 interactions through natural substances are also discussed.</p>","PeriodicalId":18581,"journal":{"name":"Military Medical Research","volume":"11 1","pages":"82"},"PeriodicalIF":16.7,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11654217/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142847019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信